Latest headlines
SonoVue® receives approval in China
Bracco Imaging S.p.A., a global leader in diagnostic imaging, recently announced that its ultrasound contrast agent SonoVue® (sulphur hexafluoride microbubbles) has been the first approved in China for use in ultrasonography of the urinary tract (voiding ultrasonography) for the evaluation of suspected or known vesicoureteral reflux (VUR) in pediatric patients. For more information about SonoVue, visit bracco.com.
New study: Improving the lives of people with dementia
Across the OECD countries, nearly 19 million people are living with dementia.The organisation's newest report presents a comprehensive cross-country assessment of the state of dementia care in OECD countries and advises a set of policies that could help improve diagnosis, strengthen access to care services, improve the quality of care, and support the families and carers of people living with dementia. The study can be assessed on the OECD website.
Launch of Multi-Stakeholder Health Roadmap to support Integrated Care
The Integrated Care Alliance (ICA), of which COCIR is a founding member, has launched its ‘Multi-Stakeholder Digital Health Roadmap’ in support of Integrated Care. The Roadmap is being launched at the 18th International Conference on Integrated Care in Utrecht hosted by the International Foundation for Integrated Care (IFIC). The Roadmap follows up on the ICA’s successful Call to Action ‘United Towards Integrated Care’ launched in the European Parliament in June 2016. Details on the COCIR website.
ESMO emphasises importance of cancer on global health agenda
At the World Health Assembly in Geneva, the European Society for Medical Oncology (ESMO) delivered two statements positioning cancer as a priority on the WHO global agenda. ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide essential secondary healthcare services to the millions of cancer patients who die prematurely due to lack of access to appropriate treatment. More info on the statements can be read on the ESMO website.
Bracco Imaging and Shanghai Pharmaceuticals join forces in ultrasound
Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Shanghai Pharmaceuticals Holding Co. Ltd., a leading pharmaceutical group in China - focused on providing innovative drugs in the field of oncology, infectious and cardiovascular diseases - have signed a collaboration agreement on new R&D activities in China. The collaboration is focused on the exploitation of the potentialities of the Bracco microbubbles technology platform, to support the development of innovative Shanghai Pharmaceuticals therapeutic drugs in the oncologic field. Details on the Bracco website.
Robocath demonstrates safety and efficacy of its R-One medical robotic platform
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today during the EuroPCR congress that its first robotic solution, R-OneTM, met all its primary efficacy and safety endpoints in the first pre-clinical study. Details about the pre-clinical study can be found at the Robocath website.
